gliptin and glp-1 sitagliptin [TUSOM Dipeptidyl peptidase 4 inhibitors in

The effects of GLP-1RAs on colorectal and other cancer risk Clinical studies have demonstrated that the use of GLP-1RAs can reduce the risk of colorectal cancer, and the protective effect appears to be positively correlated with the duration of therapy

"Top 300 of 2023"

(KPEL News) Insurance companies across the country are dropping coverage for GLP-1 weight-loss medications, and Louisiana residents are losing access to drugs like Wegovy and Zepbound

The gut microbiome and hypertension

Behavioral health treatments like cognitive behavioral therapy (CBT) can help treat AUD

Answer a few questions about your health history and weight loss goals to be shared with Ro